Epoch 51: 25 Biotech Predictions for 2025

The Best is Yet to Come!

Hello Avatar! Welcome back for another week of biotech analysis. Today is Sunday, which means this is our Building Biotech newsletter that is focused on discussing biopharma strategy topics. This is going to be a fun and provocative one. As we head into the new year it is always fun to make predictions and we have 25 of them for 2025! If you missed last week’s 2024 year in review be sure to have a look. Next week we will wrap up 2025 with buy-out predictions for 2025.

If you're not subbed yet click the link below. Every Thursday we are out with our FREE public/private biotech market update. Sundays are the days we focus on forward looking strategy. Monday’s are for public equity research. Tomorrow given the holiday we are not going to be putting out a stock pick. Alternatively we will likely drop an article on X.

Please help spread the work by subscribing and hitting the share button if you are enjoying our bi-weekly newsletters!

Enough shilling for the day, lots to cover this week, let's get started!

INTRODUCTION

As we approach 2025, the biotech industry stands at the precipice of unprecedented transformation. With scientific innovation accelerating and new challenges reshaping the global healthcare landscape, the next year promises to be one of bold moves, unexpected breakthroughs, and paradigm-shifting ideas. To capture the essence of this moment, we’ve compiled 205 provocative and bold predictions that forecast the most transformative trends, opportunities, and disruptions in biotech for the year ahead. From groundbreaking advancements in gene and epigenetic editing to shifts in regulatory landscapes and the rise of AI-powered drug discovery, these predictions aim to spark thought, conversation, and action. This is not just a look into the future—it’s a roadmap to where biotech is heading and the opportunities that lie within.

1. Long COVID Becomes a Blockbuster Discussion